Clinical Trials

Industry-sponsored clinical trials have enrolled significantly more participants than federally sponsored trials over the past decade, according to retrospective study results.

Health Canada has approved Daybue to treat Rett syndrome in patients aged 2 years and older, according to manufacturer Acadia Pharmaceuticals.

In this episode, host Shikha Jain, MD, speaks with Amita Patnaik, MD, FRCPC, about providing patient access to breakthrough drug developments, bringing early phase cancer trials to physicians and more.

Early initiation and continuation of Kesimpta in those with relapsing MS was associated with lower rates of disability worsening up to 6 years compared with those who switched medication, according to a presentation at ECTRIMS 2024.

Although progress has been made, lack of diversity continues to be problematic in trials of immune checkpoint inhibitors, according to study results.

Most cancer clinical trials use inaccurate tests to evaluate kidney function when determining participant eligibility, according to results of a cross-sectional study.

Topline results from the open-label RESTORE trial showed that chloral hydrate improved symptoms of severe insomnia at 14 days in patients for whom previous behavioral and pharmaceutical solutions have failed.

A New York-based biotechnology company has received a $4 million grant from the NIH’s National Institute on Aging to advance a novel intranasal therapeutic to treat Alzheimer’s disease, according to a press release from the manufacturer.

ORLANDO, Fla. — The highest priority in boosting clinical trial representation in MS is utilizing corrective methods to reverse generational actions that led to mistrust in affected groups or individuals, according to a speaker.

Aviceda Therapeutics has completed enrollment of its phase 2b SIGLEC study, which will compare the safety and efficacy of AVD-104 vs. Izervay in patients with geographic atrophy secondary to age-related macular degeneration.